Does Timing of Levonorgestrel Insertion in Women with Abnormal Uterine Bleeding Affect its Expulsion and Bleeding Pattern? A Follow-Up Study
Insertion of levonorgestrel-IUS between days 8–15 showed the lowest risk of moderate/heavy bleeding and favorable expulsion rates compared to luteal phase insertion.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This follow-up study evaluated whether the day of levonorgestrel intrauterine system (LNG-IUS) insertion relative to last menstrual period (LMP) affects expulsion rates and subsequent irregular bleeding patterns in 76 women with abnormal uterine bleeding, grouping participants into four insertion-day categories. The main finding was that earlier (22–30 day, luteal phase) insertion was associated with faster expulsions (25% by 3 months) and that from 6 months onward expulsion rates were higher in the luteal than follicular phase (p < 0.03). For bleeding outcomes, the lowest risk of moderate/heavy bleeding occurred with insertion on days 8–15 (odds ratio 0.03; 95% CI 0.01–0.2) compared with the 22–30 day group. A limitation explicitly noted in the abstract-level reporting is that the analysis focuses on timing effects within this specific AUB cohort, without broader stratification details beyond the insertion-day groups. Relevance to endometriosis: the study’s AUB population includes adenomyosis (36.84%) as a major indication, so LNG-IUS insertion timing outcomes are directly applicable to adenomyosis-associated abnormal uterine bleeding.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
6,291 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Methods
Results
Conclusion
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (13)
- Abnormal uterine bleeding via openalex
- Management of endometrial hyperplasia. via openalex
- W1827097019 via openalex
- W2007883657 via openalex
- W2040695674 via openalex
- W2137817553 via openalex
- W2790094279 via openalex
- W2895040563 via openalex
- W2918187843 via openalex
- W2954158763 via openalex
- W3112884055 via openalex
- W4237542082 via openalex
- W1805384318 via openalex
SciLite annotations
chemicals 4
organisms 2
Source provenance
- europepmc
- last seen: 2026-08-02T06:10:09.037253+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-08-02T06:09:26.598398+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00